BXP enters the first week of August with short sellers rebuilding positions after the stock's post-earnings jump, even as the borrow market and analyst community signal the bears face little structural tailwind.
The earnings release on July 28 delivered a 5.4% one-day gain and the stock has held most of that move, closing at $70.67 — up about 1% on the week and nearly 2% over the past month. The post-earnings bounce reversed a trend of steady short-side accumulation from earlier in July, but shorts have since crept back. Short interest now stands at 7.1% of the free float, up 2.1% on the week and reversing roughly half of the month-long decline flagged in the pre-earnings note published July 29. That note observed SI easing to 6.9% of float; the rebound to 7.1% marks a clear directional shift in bear positioning post-print.
The borrow market tells a more relaxed story. Borrowing costs are running near the low end of their recent range at 0.43%, barely changed on the week, and availability remains exceptionally loose at 620% — meaning six shares are available to borrow for every one currently shorted. That is far from squeeze territory and suggests the short rebuild reflects considered re-entry rather than any stress in the lending pool. Options positioning has tightened slightly, though. The put/call ratio has nudged up to 0.578, about 1.3 standard deviations above its 20-day average of 0.50 — not extreme, but the highest reading in roughly two weeks. The 52-week range on the PCR runs from 0.39 to 1.25, so current levels are elevated relative to recent norms without being alarming. Together, the positioning picture looks cautious rather than aggressive: shorts are quietly rebuilding while options traders hedge at the margin.
The Street moved decisively in BXP's favour around earnings. Nearly every firm that updated targets did so to the upside — Barclays lifted to $79 from $65, Piper Sandler raised to $86 from $75, and within the past two days Scotiabank bumped its target to $76 (from $74, maintaining Sector Outperform) while Citigroup raised to $69 from $58, though it kept a Neutral rating. The consensus mean target now sits at $74.20, roughly 5% above the current price. The split between the bulls — Piper Sandler's $86 target implies meaningful upside — and the cautious holders — Citigroup and Mizuho both neutral in the high $60s — reflects an unresolved debate over lease economics and flat organic growth that the bear case articulates clearly. The EV/EBITDA multiple of 14.7x has eased slightly over the past month, and the PE of 34.6x has ticked up, suggesting the market is paying for recovery optionality rather than current earnings. The ORTEX short score sits at 55.6, mid-range and stable, consistent with meaningful but not extreme short-side pressure.
On the ownership side, Cohen & Steers added over 5.4 million shares in the quarter to March, making it the largest holder at nearly 13% of shares. First Eagle added over 5.9 million shares through May, taking a 5.9% stake. Both are meaningful conviction adds from specialist real estate managers. The CFO's sale of roughly $1.7 million of stock in June — following an award at the same time — reads as routine rather than signalling, particularly given the scale of institutional inflows on the other side.
The next scheduled earnings event is October 27, leaving roughly twelve weeks of trading before the next catalyst. In the near term, the degree to which the fresh short-side interest continues to build — or fades again as it did through most of July — will say most about whether the post-earnings recovery has real conviction behind it.
See the live data behind this article on ORTEX.
Open BXP on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
